Skip to main content
Fig. 1 | Clinical Epigenetics

Fig. 1

From: BladMetrix: a novel urine DNA methylation test with high accuracy for detection of bladder cancer in hematuria patients

Fig. 1

The overall strategy for biomarker discovery and evaluation of the BladMetrix test performance in urine. The figure gives an overview of the overall strategy for identification of accurate biomarkers for bladder cancer detection (upper part), and evaluation of the best performing biomarkers as a panel, i.e., the BladMetrix test, in urine (lower part). BlCa Bladder cancer; NBM Normal bladder mucosa; HC Healthy controls; PrCa Prostate cancer; ReCa Renal cancer; NPV Negative predictive value; PPV Positive predictive value. Figure created with BioRender.com

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us